[Seite 83↓]

Literaturverzeichnis

1 Achenbach T, Seifert JK, Pitton MB, Schunk K, Junginger T : Chemoembolization for primary liver cancer , EJSO 2002 ; 28 : 37-41

2 Adams GE, Bremner JCM, Stratford IJ, Wood PJ: Can31 P magnetic resonance spectroscopy measurements of changes in experimental tumor metabolism be related to modification of oxygenation status?, BJR Supl. 1992; 24: 137-141

3 Bates TE, Williams SR, Gadian DG: Phosphodiesters in the liver: the effect of field strength on the 31 P signal, Magn Reson Med 1989; 12: 145-150

4 Bauer H, Negishi C, Weinmann HJ: Influence of gadolinium chelates on phosphorus-31 magnetic resonance spectroscopy of the liver, Invest Radiol 1994; 29,8: 752-757

5 de Beer R, Bachert-Baumann P, Bovée WMMJ, Cady E, Chambron J, Dommisse R, van Echteld CJA, Mathur-de Vre R, Williams SR: Quality assessment in in vivo NMR spectroscopy: VI Multicentre quantification of MRS test signals, Magn Reson Imaging 1995; 13,1: 169-176

6 Bismuth H, Fecteau A : Kombinationstherapie in der Onkologie – das hepatozelluläre Karzinom , Chirurg 1998 ; 69 : 360-365

7 Boesch C, Elsing C, Wegmüller H, Felblinger J, Vock P, Reichen J: Effect of ethanol and fructose on liver metabolism: a dynamic 31 phopsphorus magentic resonance spectroscopy study in normal volunteers, Magn Reson Imaging 1997; 15,9: 1067-1077

8 van den Boogaart A, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR: In vivo 31 P MRS: absolute concentrations, signal-to-noise and prior knowledge, NMR Biomed 1995; 8: 87-93

9 Bourdel-Marchasson I, Biran M, Thiaudière, Delalande C, Decamps A, Manciet G, Canoni P 31 P magnetic resonance spectroscopy of human liver in elderly patients: changes according to nutritional status and inflammatory state, Metabolism 1996; 45,9: 1059-1061

10 Brinkmann G, Melchert UH, Lalk G, Heller M : 31P-MR-Spektroskopie von Lebererkrankungen unter Berücksichtigung von unterschiedlichen Pulswiederholungszeiten , Fortschr. Röntgenstr. 1993; 159,5: 412-418


[Seite 84↓]

11 Brinkmann G, Melchert UH, Emde L, Wolf H, Muhle C, Brossmann J, Reuter M, Heller M: In vivo P-31-MR-spectroscopy of focal hepatic lesions: Effectiveness of tumor detection in clinical practice and experimental studies of surface coil characteristics and localization technique, Invest Radiol 1995; 30,1: 56-63

12 Brinkmann G, Melchert UH, Muhle C, Brossmann J, Link J, Reuter M, Heller M: Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases, Eur Radiology 1996; 6: 62-65

13 Brinkmann G, Melchert UH, Lalk G, Emde L, Link J, Muhle C, Steffens JC, Heller M: The total entropy for evaluating 31 P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases, Invest Radiol 1997; 32,2: 100-104

14 Brown TR, Kincaid BM, Ugurbil K: NMR chemical shift imaging in three dimensions, Proc Natl Acad Sci USA 1982; 79: 3523-3526

15 Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MDC, Vilana R, Rodes J: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution, Hepatology 1998; 27,6: 1578-1583

16 Buchli R, Meier D, Martin E, Boesiger P: Assesment of absolute metabolite concentrations in human tissue by 31 P MRS in vivo. Part II: muscle, liver, kidney, Magn Reson Med 1994; 32: 453-458

17 Castrucci M, Sironi S, de Cobelli F, Salvioni M, del Maschio A: Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization, Abdom Imaging 1996; 21: 488-494

18 Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL : A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma , Cancer 2002 ; 94 , 6 : 1747-1752

19 Changani KK, Jalan R, Cox IJ, Ala-Korpela M, Bhakoo K, Taylor-Robinson SD, Bell JD : Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy , Gut 2001 ; 49 : 557-564


[Seite 85↓]

20 Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, Lee HS, Kim CY, Han MC: Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings, Radiology 1992; 182,3: 709-713

21 Chung JW: Transcatheter arterial chemoembolization of hepatocellular carcinoma, Hepato-Gastroenterology 1998; 45: 1236-1241

22 Cox IJ, Sargentoni J, Calam J, Bryant DJ, Iles RA: Four-dimensional phosphorus-31 chemical shift imaging of carcinoid metastases in the liver, NMR Biomed 1988; 1,1: 56-60

23 Cox IJ, Bryant DJ, Collins AG, George P, Harman RR, Hall AS, Hodgson HJF, Khenia S, McArthur P, Spencer DH, Young IR: Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver, J Comp Assist Tom 1988; 12,3: 369-376

24 Cox IJ, Coutts GA, Gadian DG, Ghosh P, Sargentoni J, Young IR: Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver, Magn Reson Med 1991; 17: 53-61

25 Cox IJ, Menon DK, Sargentoni J, Bryant DJ, Collins AG, Coutts GA, Iles RA, Bell JD, Benjamin IS, Gilbey S, Hodgson HJF, Morgan MY: Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques, J Hepatology 1992; 14: 265-275

26 Cox IJ, Bell JD, Peden CJ, Iles RA, Foster CS, Watanapa P, Williamson RCN: In vivo and in vitro 31 P magnetic resonance spectroscopy of focal hepatic malignancies, NMR Biomed 1992; 5: 114-120

27 Dagnelie PC, Sijens PE, Kraus DJA, Planting AST, van Dijk P : Abnormal liver metabolism in cancer patients detected by 31P MR spectroscopy , NMR Biomed 1999 ; 12 : 535-544

28 Eichler K, Mack MG, Straub R, Engelmann K, Zangos S, Woitaschek D, Vogl TJ : Oligonoduläres hepatozelluläres Karzinom (HCC): MR-gesteuerte laserinduzierte Thermotherapie (LITT) : Radiologe 2001 ; 41 , 10 : 915-922

29 Francis IR, Chenevert TL, Gubin B, Collomb L, Ensminger MSW, Walker-Andrews S, Glazer GM: Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging, Radiology 1991; 180: 341-344


[Seite 86↓]

30 Гранов АМ Тарасов ПГ Гранов ДА: Интервенционная радиология в лечении первичного и метастатического рака печени, Вестник рентгенологии и радиологии 1998; 2: 25-31

31 Gross-Fengels W, Friedmann G, Kuhn M, Huber R, Dommasck J, Neufang KFR : Techniken, Ergebnisse und Risiken der Chemoembolisation von malignen Lebertumoren , Akt Radiol 1991 ; 1 : 97-104

32 Grote R, Schmoll E, Rosenthal H, Bokemeier B : Chemoembolisation hepatozellulärer Karzinome – computertomographische Verlaufsbeobachtung , Fortschr. Röntgenstr. 1989 ; 151 ,1 : 15-22

33 Groupe d´Etude et de traitement du Carcinome Hepatocellulaire : A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma , N Engl J Med 1995 ; 332 ,19 : 1256-1261

34 Haage P, Tacke J : MR-gesteuerte perkutane Kryotherapie von Lebermetastasen , Radiologe 2001 ; 41 , 1 : 77-83

35 Hashimoto T, Nakamura H, Tomada K, Murakami T, Nakanishi K, Tsuda K, Ishida T, Kim T, Narumi Y : Hepatocellular carcinoma patients showing long-term complete resonses to chemoembolization , Seminars in Oncology 1997 ; 24 ,2(Suppl6) : S26-S28

36 Heindel W, du Mesnil de Rochemont R, Kugel H, Ernst S, Tesch H, Diehl V, Lackner K : 31P-MR-Spektroskopie der menschlichen Leber – spektrale Hinweise auf eine Lymphominfiltration , Fortschr. Röntgenstr. 1997 ; 167 ,1 : 62-70

37 Helmberger T, Holzknecht N, schöpf U, Kulinna C, Rau H, Stäbler A, Reiser M : Radiofrequenzablation von Lebermetastasen , Radiologe 2001 ; 41 , 1 : 69-76

38 Howe FA, Stubbs M, Rodrigues LM, Griffiths JR: An assessment of artefacts in localized and non-localized 31 P MRS studies of phosphate metabolites and pH in rat tumours, NMR Biomed 1993; 6: 43-52

39 Howells SL, Maxwell RJ, Howe FA, Peet AC, Stubbs M, Rodrigues LM, Robinson SP, Baluch S, Griffiths JR: Pattern recognition of 31 P magnetic resonance spectroscopy tumor spectra obtained in vivo, NMR Biomed 1993; 6: 237-241


[Seite 87↓]

40 Huppert PE, Viebahn R, Duda SH, Lauchart W : Interventionell-radiologische Therapieverfahren beim hepatozellulären Karzinom , Zentralbl Chir 1994 ; 119 ,11 : 787-793

41 Huppert PE, Geißler F, Duda SH, Lauchart W, Dette S, Dietz K, Brambs HJ, Claussen CD : Chemoembolisation des hepatozellulären Karzinoms: computertomografische Befunde und klinische Resultate bei prospektiv reptitiver Therapie , Fortschr. Röntgenstr. 1994 ; 160 ,5 : 425-432

42 Jalan R, Sargentoni J, Coutts GA, Bell JD, Rolles K, Burroughs AK, Taylor-Robinson SD : Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models , Gut 1996 ; 39 : 141-146

43 Kettenbach J, Pokrajac B, Schamp S, Fellner C, Schmid R, Gustorff B, Berger J, Grgurin M, Peer K, Wolff U, Seitz W, Pötter R, Lammer J : MR-gestützte Brachytherapie nichtresektabler Lebermetastasen , Radiologe 2001 ; 41 , 1 :56-63

44 Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H: Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma , Cancer 2001 ; 92 : 1516-1524

45 Kooby DA, Zakian KL, Challa SN, Matei C, Petrowsky H, Yoo HH, Koutcher JA, Fong Y : Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection , Cancer Research 2000 ; 60 : 3800-3806

46 Le Duc G, Elst LV, Colet JM, Roch A, Gillis P, Le Bas JF, Muller RN : Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study , J Magn Reson Imaging 2001 ; 13 : 619-626

47 Leij-Halfwerk S, Dagnelie PC, van den Berg JW, Wilson JHP, Sijens PE : Hepatic sugar phosphate levels reflect gluconeogenesis in lung cancer: simultaneous turnover measurement and 31 P magnetic resonance spectroscopy in vivo , Clincal Science 2000 ; 98 : 167-174

48 Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR: Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear overhauser effect enhanced 31 P NMR spectra localized by three-dimensional chemical shift imaging, NMR Biomed 1996; 9: 141-155


[Seite 88↓]

49 Lladó L, Virgili J, Figueras J, Valls C, Dominguez J, Rafecas A, Torras J, Fabregat J, Guardiola J, Jaurrieta E : A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization , Cancer 2000 ; 88 , 1 : 50-57

50 Luyten PR, Groen JP, Vermeulen JWAH, den Hollander JA: Experimental approaches to image localized human 31 P NMR spectroscopy, Magn Reson Med 1989; 11: 1-21

51 Matson GB, Twieg DB, Karczmar GS, Lawry TJ, Gober JR, Valenza M, Boska MD, Weiner MW: Application of image-guided surface coil P-31 MR spectroscopy to human liver, heart and kidney, Radiology 1988; 169,2: 541-547

52 Menon DK, Harris M, Sargentoni J, Taylor-Robinson SD, Cox IJ, Morgan MY: In vivo hepatic 31 P magnetic resonance spectroscopy in chronic alcohol abusers, Gastroenterology 1995; 108,3: 776-788

53 Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY: Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances, Hepatology 1995; 21,2: 417-427

54 Meyerhoff DJ, Karczmar GS, Weiner MW: Abnormalities of the liver evaluated by 31 P MRS, Invest Radiol 1989; 24: 980-984

55 Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW: Alcoholic liver disease: quanitative image-guided P-31 MR spectroscopy, Radiology 1989; 173,2: 393-400

56 Meyerhoff DJ, Karczmar GS, Matson GB, Boska MD, Weiner MW: Non-invasive quantitation of human liver metabolites using image-guided 31 P magnetic resonance spectroscopy, NMR Biomed 1990; 3,1: 17-22

57 Meyerhoff DJ, Karczmar GS, Valone F, Venook A, Matson GB, Weiner MW: Hepatic cancers and their response to chemoembolization therapy: quantitative image-guided 31 P magnetic resonance spectroscopy, Invest Radiol 1992; 27: 456-464

58 Miller DL, O´Leary TJ, Girton M: Distribution of iodized oil within the liver after hapatic arterial injection, Radiology 1987; 162,3: 849-852


[Seite 89↓]

59 Munakata T, Griffiths RD, Martin PA, Jenkins SA, Shields R, Edwards RHT: An in vivo 31 P MRS study of patients with liver cirrhosis: progress towards an non-invasive assessment of disease severity, NMR Biomed 1993; 6: 168-172

60 Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M: Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization, Radiology 1983; 147,2: 401-405

61 Nakamura H, Hashimoto T, Hiromichi O, Sawada S: Transcatheter oily chemoembolization of hepatocellular carcinoma, Radiology 1989; 170,3: 783-786

62 Ng TC, Evanochko WT, Hiramoto RN, Ghanta VK, Lilly MB, Lawson AJ, Corbett TH, Durant JR, Glickson JD: 31P NMR spectroscopy of in vivo tumors, J Magn Reson 1982; 49: 271-286

63 Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK: Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy, Lancet 1986; July: 8-11

64 Oberhaensli RD, Galloway GJ, Hilton-Jones D, Bore PJ, Styles P, Rajagopalan B, Taylor DJ, Radda GK: The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy, BJR 1987; 60: 367-373

65 Okada S: Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues, Hepatology 1998; 27,6: 1743-1744

66 Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z : Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization , Radiology 2001 ; 219 , 3 : 669-678

67 Pelletier G, Ducreux M, Gay F, Luboinski M, Hagège H, Dao T, van Steenberg W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial, J Hepatology 1998; 29: 129-134

68 Rajanayagam V, Lee RR, Ackerman Z, Bradley WG, Ross BD: Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis, JMRI 1992; 2,2: 183-190


[Seite 90↓]

69 Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, Rameé A, Herry JY, Gastard J: Hepatic artery injection of I-131-labeled lipiodol, Radiology 1988; 168,2: 541-545

70 Reiman TH, Heiken JP, Totty WG, Lee WKT: Clinical MR imaging with a Helmholtz-type surface coil, Radiology 1988; 169,2: 564-566

71 Roelsgaard K, Stodkilde-Jorgensen H, Donstrup S, Djurhuus JC: Non-invasive investigation of parenchymal liver disease using 31 P NMR spectroscopy, NMR Biomed 1993; 6: 383-388

72 Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, Yoshino M, Moriyama N, Sugita M: Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma, Jpn J Clin Oncol 1997; 27,4: 251-257

73 Sangro B, Herràiz M, Martìnez-Gonzàles MA, Bilbao I, Herrero I, Beloqui O, Betés M, de la Pena A, Cienfuegos JA, Quiroga J, Prieto J: Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single european institution, Surgery 1998; 124,3: 575-583

74 Sauter R, Schneider M, Wicklow K, Kolem H : Klinisch einsetzbare Verfahren der Magnetresonanz-Spektroskopie – heutiger Stand , electromedica 1992 ; 60 ,2 : 32-54

75 Schilling A, Gewiese B, Stiller D, Römer T, Wolf KJ: Influence of nutritional status on the 31 P-MR spectrum of the healthy liver, Fortschr. Röntgenstr. 1990; 153,4: 369-372

76 Schilling A, Gewiese B, Berger G, Boese-Landgraf J, Fobbe F, Stiller D, Gallkowski U, Wolf KJ: Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization, Radiology 1992; 182,3: 887-890

77 Scholz A, Langer M, Langer R, Felix R, Neuhaus P : Intraarterielle Chemoembolisation nicht-resektabler hepatozellulärer Karzinome , Fortschr. Röntgenstr. 1991 ; 154 ,3 : 258-261

78 Semmler W, Gademann G, Bachert-Baumann P, Zabel HJ, Lorenz WJ, van Kaick G : Monitoring human tumor response to therapy by means of P-31 spectroscopy , Radiology 1988 ; 166 ,2 : 533-539

79 Sijens PE, van Dijk P, Dagnelie PC, Oudkerk M: Non-T1-weighted chemical shift imaging of the human liver, Magn Reson Imaging 1995; 13,4: 621-628


[Seite 91↓]

80 Sijens PE, Dagnelie PC, Halfewerk S, van Dijk P, Wicklow K, Oudkerk M: Understanding the discrepancies between 31 P MR spectroscopy assessed liver metabolite concentrations from different institutions, Magn Reson Imaging 1998; 16,2: 205-211

81 Sostman HD, Armitage IM, Fischer JJ: NMR in cancer: I. High resolution spectroscopy of tumors, Magn Reson Imaging 1984; 2,4: 265-278

82 Steen RG: Response of solid tumors to chemotherapy monitored by in vivo 31 P nuclear magnetic spectroscopy: a review, Cancer Res 1989; 49: 4075-4085

83 Steger W, Vogl TJ, Hosten N, Steger S, Hidajat N, Felix R: Dopplersonographische Verlaufskontrolle der Perfusion hepatozellulärer Karzinome nach arterieller Chemoembolisation, Fortschr. Röntgenstr. 1998; 168,1: 49-56

84 Stubbs M, Rodrigues LM, Griffiths JR: Potential artefacts from overlying tissues in 31 P NMR spectra of subcutaneously implanted rat tumours, NMR Biomed 1989; 1,4: 165-170

85 Stubbs M, Rodrigues LM, Gusterson BA, Griffiths JR: Monitoring tumor growth and regression by 31 P magnetic resonance spectroscopy, Advan Enzyme Regul 1990; 30: 217-230

86 Stubbs M, Veech RL, Griffiths JR: Tumor metabolism: the lesson of magnetic resonance spectroscopy, Advan Enzyme Regul 1995; 35: 101-115

87 Taylor-Robinson SD, Sargentoni J, Bell JD, Saeed N, Changani KK, Davidson BR, Rolles K, Burroughs AK, Hodgson HJF, Foster CS, Cox IJ: In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron spectroscopy of the cirrhotic liver, Liver 1997; 17: 198-209

88 Taylor-Robinson SD : Applications of magnetic resonance spectroscopy to chronic liver disease , Clincal Medicine 2001 ; 1 , 1 : 54-60

89 Thomas CP, Dixon RM, Tian M, Butler SA, Counsell CJR, Bradley JK, Adams GE, Radda GK: Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31 P magnetic resonance spectroscopy in vivo and in vitro, Br J Cancer 1994; 69: 633-640

90 Tofts PS, Wray S: A critical assessment of methods of measuring metabolite concentrationd by NMR spectroscopy, NMR Biomed 1988; 1,1: 1-10


[Seite 92↓]

91 Trinchet JC, Ganne-Carrie N, Beaugrand M: Intra-arterial chemoembolization in patiens with hepatocellular carcinoma, Hepato-Gastroenterology 1998; 45: 1242-1247

92 Troisi R, Defreyne L, Hesse UJ, Praet M, Decruyenaere J, de Hemptinne B: Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization an alcoholization before liver transplantation, Clin Transplantation 1998; 12: 313-319

93 Twieg DB, Meyerhoff DJ, Hubesch B, Roth K, Sappey-Marinier D, Boska MD, Gober JR, Schaefer S, Weiner MW: Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: localized spectroscopy and metabolite imaging, Magn Reson Med 1989; 12: 291-305

94 Vogl TJ, Schroeder H, Trapp M, Straub R, Schuster HA, Schuster M, Mack M, Souchon F, Neuhaus P : Multisequentielle arterielle Chemoembolisation fortgeschrittener hepatozellulärer Karzinome: computertomografische Verlaufsparameter zur Beurteilung des Ansprechens auf Therapie , Fortschr. Roentgenstr. 2000 ; 172 : 43-50

95 Vogl TJ, Schroeder H, Trapp M, Mack M, Schuster HA, Schmitt J, Neuhaus P, Felix R : Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success – results from a liver transplantation center , Radiology 2000 ; 214 ,2 : 349-357

96 Vogl TJ, Mack M, Straub R, Eichler K, Engelmann K, Roggan A, Zangos S : Perkutane interstitielle Thermotherapie maligner Lebertumoren , Fortschr. Roentgenstr. 2000 ; 172 : 12-22

97 Vogl TJ, Müller PK, Mack MG, Straub R, Engelmann K, Neuhaus P : Therapiemöglichkeiten bei nicht resektablen Lebermetastasen , Chirurg 1999 ; 70 : 133-140

98 van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WPTM : 31P magnetic resonance spectroscopy of the liver: correlationwith standardized serum, clinical and histological changes in diffuse liver disease , Hepatology 1995 ; 21 ,2 : 443-449

99 Wickenhöfer R, Hasan I, Schüller H, Reiser M, Hartlapp JH : Ergebnisse der Chemoembolisation fortgeschrittener Leberzellkarzinome , Fortschr. Röntgenstr. 1992 ; 156 ,4 : 328-332


[Seite 93↓]

100 Wicklow K, Kolem H, Schneider M, Sauter R : Klinische Magnetresonanzspektroskopie: Möglichkeiten und Methoden an Ganzkörpertomographen , Akt Radiol 1993 ; 3 : 90-99

101 Witte G, Kremer B, Henne-Bruns D, Jordan A, Bücheler E : Chemoembolisation beim primären Leberzellkarzinom , Fortschr. Röntgenstr. 1991 ; 154 ,6 : 634-637

102 Yamada T, Makita F, Takehara K, Saitou S, Satou K, Endou K, Shimoda R, Matsuzaki Y, Matsumoto T, Yuasa K, Takagi H, Yamada S, Mori M : Evaluation of the therapeutic effect of TAE on primary liver cancer , Cancer Chemother Pharmacol 1994 ; 33(Suppl) : S55-S59

103 Yoshioka H, Sato M, Sonomura T, Terada M, Kishi K, Yoshikawa A: Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma, Seminars in Oncology 1997; 24,2(Suppl6): S29-S37

104 Zangos S, Gille T, Eichler K, Engelmann K, Woitaschek D, Balzer JO, Mack MG, Thalhammer A, Vogl TJ : Transarterielle Chemoembolisation bei hepatozellulären Karzinomen: Technik, Indikationsstellung, Ergebnisse , Radiologe 2001 ; 41 : 906-914

105 Zangos S, Mack MG, Straub R, Engelmann K, Eichler K, Balzer JO, Vogl TJ : Transarterielle Chemoembolisation (TACE) von Lebermetastasen , Radiologe 2001 ; 41, 1 : 84-90

106 Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M : The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma , Cancer 2000 ; 89 , 12 : 2606-2612


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
04.08.2003